Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LENS-Pharm is a Russian pharmaceutical manufacturer based in the Vladimir region and operates as a subsidiary of Veropharm, which is owned by Abbott. The company is a major producer of oncology medications, including a wide range of cytostatic drugs in various forms such as concentrates, lyophilisates, and tablets. Its production facilities are compliant with international Good Manufacturing Practice (GMP) standards, ensuring the supply of high-quality essential medicines to the Russian market. As part of the Abbott group, LENS-Pharm integrates global pharmaceutical expertise with local manufacturing excellence to address critical healthcare needs in Russia. The facility serves as a core manufacturing hub for Veropharm's oncology portfolio, supporting the domestic production of life-saving treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ЛЭНС-Фарм.